Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBIShell Companies
-$0.18 today
- Market cap
- $85.57M
- Beta
- 0.21
- P/E (TTM)
- 18.0
- EPS (TTM)
- $1.03
Volume 0.00M
Average 0.00M
CPBI EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Central Plains Bancshares, Inc. Common StockNASDAQ: CPBI
EBITDA · Q3 FY2025 · quarter ended Dec 2025
EBITDA growth accelerates
Q3 FY2025 EBITDA of $1.73M rose 31.3% year over year, ahead of the +12.4% change in trailing-twelve-month EBITDA. Sequentially, it rose 24.0% from the prior quarter. Over 3 fiscal years it compounded at +5.5% a year.
Context
- EBITDA amounted to 18.2% of revenue in FY2024, down 3.4 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $2.03B (+40695.0%) for the fiscal year ending Mar 2026, a step up from the -3.4% reported in FY2024.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterDec 2025
- $1.73M+24.0% QoQ
- Last fiscal yearMar 2025
- $4.98M-3.4% YoY
- LTMDec 2025
- $5.69M+12.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +31.3% | — | — |
| 1 year | -3.4% | +40695.0% | +40698.4 pp |
| 3-year CAGR | +5.5% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2024
- 4.98M USD
- Year-over-year change
- -3.4%
- 3-year CAGR
- +5.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 4.98M | -3.4% |
| FY2023 | 2024-03-31 | 5.15M | +109.0% |
| FY2022 | 2023-03-31 | 2.47M | -41.8% |
| FY2021 | 2022-03-31 | 4.24M | — |
EBITDA vs competitors
How CPBI compares with its peers on the latest reported figures
- CPBI's LTM Dec 2025 EBITDA of $5.69M is the 3rd highest of the 8 companies compared; the peer median is -$248.91K.
- Its year-over-year change of +12.4% is the highest of 6, against a peer median of -10.1%.
- EBITDA amounts to 19.2% of revenue for CPBI, versus a peer median of 18.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $10.72M | +5.6% | -3.1% | 18.1% | |
| LTM Mar 2026 | $9.78M | -18.8% | -4.0% | 15.3% | |
| LTM Dec 2025 | $5.69M | +12.4% | +5.5% | 19.2% | |
| LTM Mar 2026 | $5.08M | -10.1% | +0.5% | 93.0% | |
| LTM Mar 2026 | -$248.91K | — | — | — | |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | -$484.33K | -135.0% | — | — |
ORIQUOrigin Investment Corp I Units | LTM Mar 2026 | -$736.94K | — | — | — |
| LTM Mar 2026 | -$1.19M | -4.3% | — | — | |
| Peer median (excluding CPBI) | -$248.91K | -10.1% | -3.1% | 18.1% | |
Competitors are the stored peer set for CPBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|
| Revenue | 15.68M | 18.42M | 23.82M | 27.31M |
| Cost of Revenue | 965K | 5.62M | 6.58M | 8.41M |
| Gross Profit | 14.71M | 12.8M | 17.24M | 18.9M |
| Gross Margin | 93.8% | 69.5% | 72.4% | 69.2% |
| Research & Development | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.65M | 6.18M | 7.47M | 8.49M |
| Operating Expenses | 10.97M | 10.84M | 12.6M | 14.38M |
| Depreciation & Amortization | 497K | 503K | 518K | 455K |
| EBITDA | 4.24M | 2.47M | 5.15M | 4.98M |
| EBITDA Margin | 27.0% | 13.4% | 21.6% | 18.2% |
| Operating Income | 3.74M | 1.96M | 4.64M | 4.52M |
| Operating Margin | 23.9% | 10.7% | 19.5% | 16.6% |
| Interest Income | 13.17M | 16.14M | 20.96M | 24.7M |
| Interest Expense | 1.08M | 2.74M | 6.49M | 8.21M |
| Other Income / Expenses | 0 | 0 | 0 | 0 |
| Income Before Tax | 3.74M | 1.96M | 4.64M | 4.52M |
| Pre-Tax Margin | 23.9% | 10.7% | 19.5% | 16.6% |
| Income Tax Expense | 595K | 317K | 877K | 869K |
| Net Income | 3.15M | 1.65M | 3.76M | 3.65M |
| Net Margin | 20.1% | 8.9% | 15.8% | 13.4% |
| EPS (Basic) | 0.86 | 0.45 | 1.10 | 0.96 |
| EPS (Diluted) | 0.86 | 0.40 | 1.10 | 0.96 |
| Weighted Avg Shares | 3.68M | 3.68M | 3.44M | 3.82M |
| Weighted Avg Shares (Diluted) | 3.68M | 4.13M | 3.44M | 3.82M |
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
Intrinsic Alpha fair value
Locked
Current Price
$20.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.